<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    NovoCure Limited

    NovoCure Limited

    Novocure is a global oncology company working to extend survival in some of the mo...

    Novocure is a global oncology company working t...

    Filing Type:    PU
    KalVista Pharmaceuticals, Inc.

    KalVista Pharmaceuticals, Inc.

    KalVista is a pharmaceutical company focused on the discovery, development and com...

    KalVista is a pharmaceutical company focused on...

    Filing Type:    PU
    Compugen Ltd.

    Compugen Ltd.

    Compugen is a drug discovery company with a unique, broadly applicable, predictive...

    Compugen is a drug discovery company with a uni...

    Filing Type:    PU
    Pacific Biosciences of California, Inc.

    Pacific Biosciences of California, Inc.

    Pacific Biosciences' mission is to transform the way humankind acquires, processes...

    Pacific Biosciences' mission is to transform th...

    Filing Type:    PU
    Amarantus Bioscience Holdings, Inc.

    Amarantus Bioscience Holdings, Inc.

    Amarantus BioSciences is a development-stage, publicly-traded biotechnology compan...

    Amarantus BioSciences is a development-stage, p...

    Amount Raised:    $4,300,000
    Fundraising Status:    VT
    Filing Type:    PR
    ProLung, Inc.

    ProLung, Inc.

    ProLung is a medical technology company specializing in innovative predictive anal...

    ProLung is a medical technology company special...

    Filing Type:    PU
    Tactile Systems Technology, Inc.

    Tactile Systems Technology, Inc.

    Tactile Medical is a leader in developing and marketing at-home therapy devices th...

    Tactile Medical is a leader in developing and m...

    Filing Type:    PU
    CHF Solutions, Inc.

    CHF Solutions, Inc.

    CHF Solutions is focused on improving the quality of life for patients suffering f...

    CHF Solutions is focused on improving the quali...

    Filing Type:    PU
    STAAR Surgical Company

    STAAR Surgical Company

    STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, de...

    STAAR, which has been dedicated solely to ophth...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.